CRIZANLIZUMAB, A P-SELECTIN INHIBITOR, INCREASES THE LIKELIHOOD OF NOT EXPERIENCING A SICKLE CELL-RELATED PAIN CRISIS WHILE ON TREATMENT: RESULTS FROM THE PHASE II SUSTAIN STUDY

EHA Library, Abdullah Kutlar, 181741

HIGHER FREQUENCY OF SWITCHED MEMORY B CELLS PREDICTS THE INCIDENCE OF CHRONIC GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Rima Saliba, 181737

ABERRANT T CELL RESPONSES IN THE BONE MARROW MICROENVIRONMENT OF PATIENTS WITH POOR GRAFT FUNCTION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Yuan Kong, 181736

IDENTIFICATION OF A NEW AND RELATIVELY FREQUENT SERPINC1 GENE DEFECT CAUSING ANTITHROMBIN DEFICIENCY HARDLY DETECTED BY CURRENT MOLECULAR METHODS: DUPLICATION OF EXON 6.

EHA Library, Eugenia de la Morena, 181732

IMPACT OF A NEW ELECTRONIC ALERT SYSTEM (V2.0) FOR VENOUS THROMBOEMBOLISM PREVENTION IN HOSPITALISED CANCER PATIENTS.

EHA Library, Rocío Figueroa Mora, 181731

FREE IRON IN SERA OF PATIENTS WITH SICKLE CELL DISEASE CONTRIBUTES TO THE RELEASE OF NEUTROPHIL EXTRACELLULAR TRAPS

EHA Library, Kristof Van Avondt, 181742

A MONOALLELIC LOSS-OF-FUNCTION MUTATION IN THE THROMBOPOIETIN (THPO) GENE IS RESPONSIBLE FOR A NEW FORM OF INHERITED THROMBOCYTOPENIA (IT)

EHA Library, Patrizia Noris, 181720

DEPTH OF RESPONSE AS SURROGATE MARKER FOR PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL IN ELDERLY NEWLY DIAGNOSED MYELOMA PATIENTS TREATED WITH VMP AND RD: GEM2010MAS65

EHA Library, Maria Victoria Mateos, 181696

MESENCHYMAL STROMAL CELLS STIMULATE THE PROLIFERATION AND IL-22 PRODUCTION BY TYPE 3 INNATE LYMPHOID CELLS

EHA Library, Vera van Hoeven, 181735

COMPARATIVE ANALYSIS OF PREDICTIVE MODELS FOR THROMBOEMBOLIC EVENTS IN LYMPHOMA PATIENTS

EHA Library, Darko Antic, 181730

THERAPEUTIC TARGETING OF ONCOGENIC MYB ACTIVITY IN T-ALL

EHA Library, Tim Pieters, 181725

ASSESSMENT OF IMATINIB 400MG AS FIRST LINE TREATMENT OF CHRONIC MYELOID LEUKEMIA: 10 -YEAR SURVIVAL RESULTS OF THE RANDOMIZED CML STUDY IV

EHA Library, R Hehlmann, 181711

LOSS OF RAF KINASE INHIBITOR PROTEIN IS INVOLVED IN MYELOMONOCYTIC LINEAGE COMMITMENT AND AGGRAVATES THE DEVELOPMENT OF CHRONIC MYELOMONOCYTIC LEUKEMIA IN A MURINE IN-VIVO MODEL

EHA Library, Veronica Caraffini, 181706

DISEASE CHARACTERISTICS AND SURVIVAL AFTER 3RD RECURRENCE OF CLASSICAL HODGKIN LYMPHOMA: AN ANALYSIS OF THE GERMAN HODGKIN STUDY GROUP

EHA Library, Paul Bröckelmann, 181701

HEREDITARY XEROCYTOSIS: CLINICAL AND BIOLOGICAL PRESENTATION AT DIAGNOSIS IN A RETROSPECTIVE SERIES OF 103 PATIENTS

EHA Library, loic garcon, 181740

CD4 T CELLS RECOGNIZING MISMATCHED HLA-DP AFTER ALLOGENEIC STEM CELL TRANSPLANTATION SHOW TISSUE SPECIFIC REACTIVITIES

EHA Library, Peter Balen, 181734

RISK OF THROMBOSIS IN PATIENTS WITH NON-HODGKIN'S LYMPHOMA: A POPULATION-BASED COHORT STUDY

EHA Library, Anna Maria Birgisdottir, 181729

TNF RECEPTOR 2 IS REQUIRED FOR RIP1-DEPENDENT CELL DEATH IN LEUKEMIA

EHA Library, Júlia Aguadé-Gorgorió, 181724

STEM CELL TRANSPLANTATION IN PYRUVATE KINASE DEFICIENCY

EHA Library, Stephanie van Straaten, 181739

NOVEL PERSPECTIVES IN GENOTYPE-PHENOTYPE CORRELATIONS IN MYH9-RELATED DISEASE: NO LONGER JUST A MATTER OF HEAD OR TAIL

EHA Library, Carlo Zaninetti, 181719

NUCLEOSOME BINDING PROTEIN HMGN1 BLOCKS MYELOID DIFFERENTIATION AND PROMOTES CLONAL DOMINANCE VIA ABERRANT HISTONE ACETYLATION

EHA Library, Lucia Cabal-Hierro, 181715

INITIAL REDUCTION OF THERAPY BEFORE COMPLETE WITHDRAWAL IMPROVES THE CHANCE OF SUCCESSFUL TREATMENT DISCONTINUATION IN CHRONIC MYELOID LEUKAEMIA (CML): YEAR 2 RESULTS IN THE BRITISH DESTINY STUDY

EHA Library, Richard Clark, 181710

EFFECTIVENESS OF LSD1 INHIBITION FOR THE TREATMENT OF MPN

EHA Library, Jonas Jutzi, 181705

EARLY CHEMOTHERAPY INTENSIFICATION WITH ESCALATED BEACOPP IN ADVANCED-STAGE HODGKIN LYMPHOMA WITH A POSITIVE INTERIM PET-CT AFTER 2 ABVD CYCLES: LONG-TERM RESULTS OF THE GITIL/FIL HD 0607 TRIAL

EHA Library, Andrea Gallamini, 181700

DEEP AND DURABLE RESPONSES WITH WEEKLY IXAZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA: LONG-TERM FOLLOW-UP OF PATIENTS WHO DID NOT UNDERGO SCT

EHA Library, Shaji Kumar, 181695

EFFECTS OF AG-348, A PYRUVATE KINASE ACTIVATOR, IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY: UPDATED RESULTS FROM THE DRIVE PK STUDY

EHA Library, Rachael F Grace, 181738

QUADRUPLET VS SEQUENTIAL TRIPLET INDUCTION THERAPY FOR MYELOMA PATIENTS: RESULTS OF THE MYELOMA XI STUDY.

EHA Library, Charlotte Pawlyn, 181694

CYTOSOLIC NUCLEIC ACID SENSORS PROMOTE INTESTINAL EPITHELIALINTEGRITY DURING ACUTE TISSUE DAMAGE AND PROTECT FROM GRAFT-VERSUS-HOST DISEASE

EHA Library, Hendrik Poeck, 181733

NIVOLUMAB FOR RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA AFTER AUTOLOGOUS TRANSPLANT: FULL RESULTS AFTER EXTENDED FOLLOW-UP OF THE MULTICOHORT MULTICENTER PHASE 2 CHECKMATE 205 TRIAL

EHA Library, Andreas Engert, 181699

YOU DON'T KNOW JAK: A PROGRAMMED RIBOSOMAL FRAMESHIFTING DEFECT POTENTIATES THE TRANSFORMING ACTIVITY OF THE JAK2-V617F MUTATION

EHA Library, Sergey SULIMA, 181704

DASATINIB IN CHILDREN AND ADOLESCENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP) FROM A PHASE 2 TRIAL

EHA Library, Christian Michel Zwaan, 181709

ETO2-GLIS2 RECRUITS ETO2/ERG COMPLEX AT SUPER-ENHANCERS TO CONTROL TRANSCRIPTION AND DRIVE LEUKEMIC PROPERTIES IN PEDIATRIC ACUTE MEGAKARYOBLASTIC LEUKEMIA

EHA Library, Cecile Thirant, 181714

THE COMBINATION OF ORAL ALL-TRANS RETINOIC ACID AND DANAZOL VS DANAZOL AS SECOND-LINE TREATMENT IN ADULT IMMUNE THROMBOCYTOPENIA: A MULTICENTRE, RANDOMIZED, OPEN-LABEL TRIAL

EHA Library, Yan Su, 181718

THE YING AND YANG OF JAK SIGNALING : LOSS OF USP9X BUFFERS JAK SIGNALING AND ENHANCES SURVIVAL OF CRLF2-JAK-STAT EXPRESSING B CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA.

EHA Library, Omer Schwartzman, 181723

ASSESSING THE RISK-BENEFIT OF ANTICOAGULANTS IN ELDERLY PATIENTS WITH CANCER-ASSOCIATED VENOUS THROMBOEMBOLISM: A POPULATION BASED STUDY

EHA Library, Alejandro Lazo-Langner, 181728

CRISPR/Cas9 genome editing, from mechanism to therapy

EHA Library, Jacob Corn, 184491

Fertility preservation in pre-pubertal and adolescent males

EHA Library, Rod Mitchell, 184479

Controversies in treating small clots in the leg and in the lung

EHA Library, Sebastian Schellong, 184487

AML Treatment Beyond 3+7

EHA Library, Norbert Vey, 184474

Fertility Preservation In Female Patients

EHA Library, Marie-Madeline Dolmans, 184478

Towards clinical translation of targeted gene editing in human hematopoietic stem cells

EHA Library, Luigi Naldini, 184490

Novel aspects in the diagnostic management of deep vein thrombosis and pulmonary embolism

EHA Library, Menno Huisman, 184486

What patients expect from hematologists

EHA Library, A Plate, 184477

Targeting Mutated FLT3

EHA Library, Mark J Levis, 184473

France-Belgium-Switzerland: The GRAALL Intergroup

EHA Library, Hervé Dombret, 184481

Major results and future approaches of Italian ALL study groups

EHA Library, Sabina Chiaretti, 184480

Cross-talk between inflammation and coagulation

EHA Library, Thomas Renné, 184485

The effects of chemotherapy and radiotherapy on reproduction

EHA Library, William Hamish Wallace, 184476

Molecular Diagnostics In AML

EHA Library, L Bullinger, 184472

Circulating tumor DNA in Non-Hodgkin lymphoma: Clinical and future research applications

EHA Library, Mark Roschewski, 184470

How to treat CML in 2017

EHA Library, Andreas Hochhaus, 184454

GVL And GVHD Differences And Similarities

EHA Library, Fred Falkenburg, 184458

Neurological complications of sickle cell disease

EHA Library, Fenalla Kirkham, 184462

Rare bleeding disorders - Diagnosis and treatment

EHA Library, Gili Kenet, 184466

Interim-PET as a valid biomarker for early response in malignant lymphoma; when to perform and how to assess

EHA Library, Josee Zijlstra, 184469

Do we still need bone marrow biopsies?

EHA Library, Tarec El-Galaly, 184468

Introduction EHA LyG

EHA Library, Marie Jose Kersten, 184467

Diagnosis and management of DIC and primary hyperfibrinolysis

EHA Library, Alessandro Squizzato, 184465

Iron Chelation In Hemoglobinopathies

EHA Library, Vip Viprakasit, 184461

Molecular work up and monitoring of CML patients

EHA Library, Nick Cross, 184453

The Role Of Intestinal Flora In Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

EHA Library, Marcel van den Brink, 184457

Biological and clinical relevance of fibrin clot structure

EHA Library, Nicola Mutch, 184464

Genome editing in hemoglobinopathies

EHA Library, Mitchell J. Weiss, 184460

Novel approaches to eradicate CML stem cells

EHA Library, Mhairi Copland, 184452

GvHD Prophylaxis And Treatment, New Modalities

EHA Library, Robert Zeiser, 184456

Fertility preservation in females

EHA Library, Marie-Madeline Dolmans, 192906

THE BCL-2 INHIBITOR VENETOCLAX INHIBITS NRF2 ANTIOXIDANT PATHWAY ACTIVATION INDUCED BY HYPOMETHYLATING AGENTS IN ACUTE MYELOID LEUKEMIA

EHA Library, Le Xuan Truong, 181473

FUNCTIONAL ASSESSMENT OF NOVEL DIAGNOSTIC FLT3 MUTATIONS AND INHIBITION BY KINASE INHIBITORS

EHA Library, Katherine Tarlock, 181471

H3K27ME3 LEVEL ON THE HIST1 CLUSTER: A POWERFUL EPIGENETIC BIOMARKER THAT STRATIFIES TWO GROUPS OF NPM1-MUTATED AML DIFFERING IN THEIR OUTCOME AND EXPRESSION PROFILE

EHA Library, Sylvain garciaz, 181470

IDENTIFICATION OF NOVEL GENE FUSIONS IN ACUTE MYELOID LEUKEMIA WITH COMPLEX KARYOTYPE BY TRANSCRIPTOME ANALYSIS USING RNA SEQUENCING

EHA Library, Frank Rücker, 181469

STROMA-DERIVED FACTORS STIMULATE JAK/STAT SIGNALING IN AML CELLS RESULTING IN RESISTANCE TO BCL2 INHIBITOR VENETOCLAX

EHA Library, Riikka Karjalainen, 181468

THE ESSENTIAL ROLE OF THE ENHANCERS OF POLYCOMB EPC1 AND EPC2 IN MLL-AF9 ACUTE MYELOID LEUKAEMIA IS A ‘COMPLEX' STORY

EHA Library, Niamh Mannion, 181467

ACUTE MYELOID LEUKEMIA EVOLUTION CAN BE RECONSTRUCTED BY ANALYSIS OF NON-LEUKEMIC CELLULAR SUBCOMPARTMENTS AND MULTI-LINEAGE ENGRAFTED MICE

EHA Library, Borhan Saeed, 181466

DECIPHERING THE ONCOGENIC NETWORK OF PRC2 LOSS GUIDED LEUKEMOGENISIS

EHA Library, Jan-Henning Klusman, 181464

THE PMLC62A/C65A KNOCK-IN MOUSE MODEL PROVIDES EVIDENCE FOR THE ROLE OF NUCLEAR BODY DISRUPTION IN THE PATHOGENESIS OF ACUTE PROMYELOCYTIC LEUKEMIA

EHA Library, Edwige Voisset, 181463

A DUAL BH3-MIMETIC APPROACH TARGETING BOTH BCL-2 AND MCL1 IS HIGHLY EFFICACIOUS AND WELL-TOLERATED IN ACUTE MYELOID LEUKEMIA

EHA Library, Donia Moujalled, 181462

THE LONG NON-CODING RNA HOXB-AS3 REGULATES RIBOSOMAL BIOGENESIS IN NPM1-MUTATED ACUTE MYELOID LEUKEMIA

EHA Library, Dimitrios PAPAIOANNOU, 181461

NUCLEAR RE-LOCALIZATION OF NPM1C+ INDUCES DIFFERENTIATION AND CELL GROWTH ARREST

EHA Library, Lorenzo Brunetti, 181460

BRANCHED CHAIN AMINO ACID METABOLISM REGULATES ALPHA-KETOGLUTARATE HOMEOSTASIS RESEMBLING MUTANT-IDH DRIVEN DNA HYPERMETHYLATION IN AML

EHA Library, Simon Raffel, 181459

RECURRENT MYB REARRANGEMENT IN BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM

EHA Library, KYOGO SUZUKI, 181458

INOTUZUMAB OZOGAMICIN IN COMBINATION WITH LOW-INTENSITY CHEMOTHERAPY (MINI-HYPER-CVD) AS FRONTLINE THERAPY FOR OLDER PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA: UPDATED RESULTS FROM A PHASE I/II TRIAL

EHA Library, Nicholas Short, 181457

MINIMAL DISSEMINATED DISEASE DETECTION BY FLOWCYTOMETRIC IMMUNOPHENOTYPING IN T-CELL ACUTE LYMPHOBLASTIC LYMPHOMA

EHA Library, Ganesh Viswanathan, 181456

PEDIATRIC MLL ACUTE LEUKEMIA PATIENTS SHOW DIFFERENTIAL HDAC EXPRESSION

EHA Library, Nerea Vega-Garcia, 181455

THE TETRASPANIN CD9 IS A PROGNOSTIC MARKER FOR PREDICTING SURVIVAL OUTCOMES OF PEDIATRIC B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Kam Tong Leung, 181454

MANAGEMENT AND OUTCOME OF ADULT PH+ ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PATIENTS TREATED AT THE “SAPIENZA” UNIVERSITY BETWEEN 1996 AND 2016

EHA Library, Sabina Chiaretti, 181453

CLINICAL OUTCOMES OF ELDERLY ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA - A SINGLE INSTITUTION EXPERIENCE

EHA Library, Kevin Miller, 181452

RESULTS FROM UKALL60+, A UK/HOVON COLLABORATIVE PHASE 2 STUDY IN ELDERLY PATIENTS WITH UNTREATED ACUTE LYMPHOBLASTIC LEUKAEMIA

EHA Library, Nick MORLEY, 181451

CLINICAL SIGNIFICANCE OF END OF INDUCTION MINIMAL RESIDUAL DISEASE IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) IN COMPLETE REMISSION AFTER A SINGLE CHEMOTHERAPY COURSE

EHA Library, Renato Bassan, 181450

PRO-T CELL ALL/LBL: AN ULTRA-HIGH RISK CD2-NEGATIVE DISEASE SUBTYPE IN ADULTS DEFINED BY FLOW CYTOMETRY

EHA Library, Beata Ostrowska, 181449

PROGNOSTIC SIGNIFICANCE OF MINIMAL RESIDUAL DISEASE DETECTED BY MLL FUSION GENE TRANSCRIPTS IN INFANT ACUTE LYMPHOBLASTIC LEUKEMIA. UPDATED RESULTS OF 76 PATIENTS ENROLLED INTO MLL-BABY STUDY

EHA Library, Grigory Tsaur, 181448

IKZF1Δ4-7 CAN BE EASILY SCREENED BY PCR BUT DOES NOT PREDICT OUTCOME IN ADULTS WITH ACUTE LYMPHOBLASTIC LEUKAEMIA; DATA FROM 490 PATIENTS ENROLLED ON THE UKALL14 TRIAL.

EHA Library, Rachel Mitchell, 181447

PHARMACOLOGICAL ACTIVITY OF CB-103 - AN ORAL PAN-NOTCH INHIBITOR WITH A NOVEL MODE OF ACTION

EHA Library, Dirk Weber, 181446

PRECLINICAL ACTIVITY OF ENTOSPLETINIB IN CHILDHOOD B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Sarah Tasian, 181445

IL-7 FLEXIBLY REGULATES AUTOPHAGY-DEPENDENT VIABILITY OF T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CELLS

EHA Library, Daniel Ribeiro, 181444

GENETIC ACTIVATION AND THERAPEUTIC TARGETING OF PIM1 IN T-CELL ACUTE LYMPHOBLASTIC LYMPHOMA

EHA Library, Renate De Smedt, 181443

TP53 MUTATIONS DISRUPTING DNA BINDING LEAD TO CHEMOTHERAPY RESISTANCE IN ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Malwine Pogodzinski, 181442

REPOSITIONING EXISTING DRUGS AS NOVEL THERAPEUTICS: OXIDATIVE STRESS AS A TARGET FOR HIGH-RISK LEUKAEMIA IN CHILDREN

EHA Library, Mawar Karsa, 181441

TRANSLATOME ANALYSIS OF THE T-ALL ASSOCIATED RIBOSOMAL PROTEIN L10 R98S MUTATION REVEALS ALTERED SERINE METABOLISM

EHA Library, Laura Fancello, 181440

BCL-2 INHIBITION AS NEW THERAPEUTIC OPPORTUNITY FOR RPL10 R98S MUTANT PEDIATRIC T-ALL

EHA Library, Kim Kampen, 181439

TARGETED SINGLE CELL SEQUENCING TO IDENTIFY MUTATIONAL HIERARCHY IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Jolien De Bie, 181438